RIO DE JANEIRO, Sept. 10, 2024 /PRNewswire/ — Petróleo Brasileiro S.A. – Petrobras (“Petrobras”) (NYSE: PBR) today announced the expiration and expiration date results of the previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) by its wholly-owned…
Month: September 2024
RIO DE JANEIRO, Sept. 10, 2024 /PRNewswire/ — Petróleo Brasileiro S.A. – Petrobras (“Petrobras”) (NYSE: PBR) today announced the expiration and expiration date results of the previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) by its wholly-owned…
New tool measures the impact of coaching on behavior change by gathering feedback from an individual’s manager, peers, and reports. NEW YORK, Sept. 10, 2024 /PRNewswire/ — CoachHub, the leading global digital coaching platform, today announces the launch of CoachHub Feedback, the latest…
New tool measures the impact of coaching on behavior change by gathering feedback from an individual’s manager, peers, and reports. NEW YORK, Sept. 10, 2024 /PRNewswire/ — CoachHub, the leading global digital coaching platform, today announces the launch of CoachHub Feedback, the latest…
NEW YORK, Sept. 10, 2024 /PRNewswire/ — GenNx360 Capital Partners (“GenNx360”), a New York-based private equity firm investing in middle market business services and industrial companies is thrilled to announce the promotions of Rishi Verma from Principal to Partner and Peter White from…
NEW YORK, Sept. 10, 2024 /PRNewswire/ — GenNx360 Capital Partners (“GenNx360”), a New York-based private equity firm investing in middle market business services and industrial companies is thrilled to announce the promotions of Rishi Verma from Principal to Partner and Peter White from…
If proven safe and effective throughout the remaining stages of research, segesterone acetate (SGA) could be one of the first remyelination therapies approved to treat multiple sclerosis The project is supported in part by the National Multiple Sclerosis Society’s commercial development…
If proven safe and effective throughout the remaining stages of research, segesterone acetate (SGA) could be one of the first remyelination therapies approved to treat multiple sclerosis The project is supported in part by the National Multiple Sclerosis Society’s commercial development…
(La croissance constante des activités internationales a permis aux revenus d’outre-mer de représenter 62,23 % de ses revenus d’activités principales). SHANGHAI, 10 sept. 2024 /PRNewswire/ — SANY Heavy Industry (SANY) a annoncé son rapport financier semestriel 2024 le 30 août. La société…
(La croissance constante des activités internationales a permis aux revenus d’outre-mer de représenter 62,23 % de ses revenus d’activités principales). SHANGHAI, 10 sept. 2024 /PRNewswire/ — SANY Heavy Industry (SANY) a annoncé son rapport financier semestriel 2024 le 30 août. La société…
